JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 109:1684-1687
© 2009 International Anesthesia Research Society
doi: 10.1213/ANE.0b013e3181b7c4f6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Paraskeva, A.
Right arrow Articles by Fassoulaki, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paraskeva, A.
Right arrow Articles by Fassoulaki, A.
Related Collections
Right arrow Mechanisms
Right arrow Clinical Pharmacology
Right arrow Regional Anesthesia
Right arrow Pharmacology


ANALGESIA

Ropivacaine Spinal Anesthesia Is Not Antagonized by Ondansetron Pretreatment

Anteia Paraskeva, MD, DESA*, Vassiliki Chatziara, MD*{dagger}, Ioanna Siafaka, MD*, Marianna Zotou, MD{dagger}, and Argyro Fassoulaki, MD, PhD, DEAA*

From the *Department of Anesthesiology, Aretaieio Hospital, Medical School, University of Athens; and {dagger}Department of Anesthesiology, St. Savas Hospital, Athens, Greece.

Address correspondence and reprint requests to Argyro Fassoulaki, MD, PhD, DEAA, Department of Anesthesiology, Aretaieio Hospital, 76 Vassilissis Sofias Ave., 11528 Athens, Greece. Address e-mail to fassoula{at}aretaieio.uoa.gr or afassou1{at}otenet.gr.

Abstract

BACKGROUND: We investigated a possible effect of ondansetron on the duration of sensory and motor block produced by ropivacaine.

METHODS: Fifty male patients undergoing transurethral surgery received either 8 mg oral ondansetron the evening before surgery plus IV 8 mg ondansetron 15 min before subarachnoid anesthesia or placebo. All patients received 2.2 mL of 0.75% plain ropivacaine intrathecally. Sensory and motor block were assessed 30 min after the intrathecal injection and every 30 min thereafter until recovery from the motor block.

RESULTS: Thirty minutes after spinal injection of ropivacaine, we first measured, in both groups, the time to maximum block for both sensory and motor modalities. The maximum level of the sensory block, defined as decreased sensation, was T8 in the control and T6 in the ondansetron group, and absence of sensation was defined as T11 and T9 for the control and the ondansetron groups, respectively. Regarding block duration, 180 min after spinal injection, sensory block was detected in 11 of 22 and 16 of 24 patients and motor block in 1 of 22 and 0 of 24 in the control and ondansetron groups, respectively. Sensory and motor block did not differ between groups at any measured time point.

CONCLUSIONS: Ondansetron had no effect on the subarachnoid sensory or motor block produced by ropivacaine.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.